|
|
Vol. 16.21 – 7 November, 2025
|
|
|
|
|
|
|
|
Researchers systematically and quantitatively identified genes that regulate androgen receptor (AR) protein levels with the goal of identifying next-generation AR-targeting strategies for patients with aggressive AR-driven prostate cancer. [Nature Genetics]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
Investigators revealed the clinical significance and mechanistic role of the off-pore nucleoporin, soluble POM121, as a crucial transcriptional regulator that enhances the aggressiveness of metastatic prostate cancer.
[Cancer Discovery]
|
|
|
|
|
|
By leveraging deep whole-exome sequencing of 93 tumors from 26 patients, researchers examined patterns of metastatic dissemination and clonal evolution of prostate cancer.
[Cancer Research]
|
|
|
|
|
|
Scientists showed that a high-fat diet not only accelerates prostate cancer progression but also significantly reduces sensitivity to CDK4/6 inhibitors.
[Cell Reports]
|
|
|
|
|
|
The authors demonstrated that nitric oxide signaling is dysregulated in neuroendocrine prostate cancer, thus allowing impaired S-nitrosylation of neuroblastoma-derived MYC and uncontrolled endoplasmic reticulum stress. [Cell Death Discovery]
|
|
|
|
|
|
Researchers presented an integrative multi-omics characterization of primary ex vivo cancer associated fibroblasts from seven treatment-naïve prostate cancer patients.
[Cell Death Discovery]
|
|
|
|
|
|
Scientists investigated insulin-like growth factor-1’s (IGF-1) tumor-intrinsic immune effects in prostate cancer to understand mechanisms underlying its poor immunotherapy response. [Scientific Reports]
|
|
|
|
|
|
|
|
The authors summarize the applications of CAR cell therapy in the following three major urological tumors: renal cell carcinoma, bladder cancer, and prostate cancer. [Current Urology Reports]
|
|
|
|
|
|
|
|
UMass Chan Medical School PhD candidate Katherine Murphy has received a Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship for her prostate cancer research.
[UMass Chan Medical School]
|
|
|
|
|
|
A five-year, $12.5 million grant has been awarded to researchers at University of Wisconsin–Madison to investigate metastatic, or advanced stage, prostate cancer, the second most common cause of cancer death in men. [University of Wisconsin–Madison]
|
|
|
|
|
|
|
|
December 8-11, 2025 Cold Spring Harbor, New York, United States
|
|
|
|
|
|
|
|
|
|
|
Mayo Clinic – Rochester, Minnesota, United States
|
|
|
|
|
|
|
Dana-Farber Cancer Institute – Boston, Massachusetts, United States
|
|
|
|
|
|
|
Indiana University – Indianapolis, Indiana, United States
|
|
|
|
|
|
|
University College London – London, England, United Kingdom
|
|
|
|
|
|
|
University of Miami Desai Sethi Urology Institute – Miami, Florida, United States
|
|
|
|
|
|